0001209191-21-004142.txt : 20210119 0001209191-21-004142.hdr.sgml : 20210119 20210119203240 ACCESSION NUMBER: 0001209191-21-004142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210119 DATE AS OF CHANGE: 20210119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fischer Laurent CENTRAL INDEX KEY: 0001379344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36579 FILM NUMBER: 21537126 MAIL ADDRESS: STREET 1: C/O PANACOS PHARMACEUTICALS, INC. STREET 2: 134 COOLIDGE AVENUE CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc. CENTRAL INDEX KEY: 0001501756 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205258327 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-272-6269 MAIL ADDRESS: STREET 1: 800 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc. DATE OF NAME CHANGE: 20100921 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-15 0 0001501756 Adverum Biotechnologies, Inc. ADVM 0001379344 Fischer Laurent C/O ADVERUM BIOTECHNOLOGIES, INC. 800 SAGINAW DRIVE REDWOOD CITY CA 94063 1 1 0 0 CEO and Director Common Stock 2021-01-15 4 P 0 8600 11.5338 A 16292 D Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $11.44 to $11.60. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Laurent D. Fischer, by /s/ Ron A. Metzger, Attorney-in-Fact. 2021-01-19